25-Hydroxyl Vitamin D Deficiency in Nasal Polyposis

Abstract

Introduction Vitamin D is known to have immunomodulatory functions and has action on chronic inflammatory processes, such as nasal polyposis.

Objective The present study assessed the levels of 25-hydroxy vitamin D and high-sensitivity C-reactive protein (hs-CRP) in patients with nasal polyposis, as compared with healthy control subjects, and identified their association with disease severity in nasal polyposis. It further assessed the levels of 25-hydroxyl vitamin D and hs-CRP in patients with nasal polyposis and atopy and compared it with patients with nasal polyposis without atopy.

Methods This was a cross-sectional study involving 2 groups: 80 patients with nasal polyposis and 80 healthy subjects. In patients with nasal polyposis, the disease severity is assessed by the sino-nasal outcome test (SNOT20) and by the Lund & Mackay staging system. Levels of 25-hydroxy vitamin D and hs-CRP were measured by enzyme-linked immunosorbent assay (ELISA).

Result The mean 25-hydroxyl vitamin D levels (ng/ml) was 12.01 ± 7.29 for cases and 22.87 ± 14.95 for controls, with p < 0.0001. The mean hs-CRP levels (mg/L) was 5.99 ± 2.74 in cases and 2.41 ± 1.95 in controls, with p < 0.0001. The severity of polyposis correlated negatively with serum levels of 25-hydroxy vitamin D and positively with hs-CRP.

Conclusion The study has thus shown significant correlation between vitamin D deficiency and inflammation in patients with nasal polyps.

Keywords

Vitamin D - hs-CRP - nasal polyposis

• References

• 1 Pawankar R. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 2003; 3 (01) 1-6
• 2 Fan G-K, Wang H, Takenaka H. Eosinophil infiltration and activation in nasal polyposis. Acta Otolaryngol 2007; 127 (05) 521-526
• 3 Cunliffe WJ, Berth-Jones J, Claudy A. , et al. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992; 26 (5 Pt 1): 736-743
• 4 Johnson CS, Hershberger PA, Trump DL. Vitamin D-related therapies in prostate cancer. Cancer Metastasis Rev 2002; 21 (02) 147-158
• 5 Hackstein H, Thomson AW. Dendritic cells: emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 2004; 4 (01) 24-34
• 6 Arshi Saba, Ghalehbaghi B, Kamrava SK, Aminlou M. Vitamin D serum levels in allergic rhinitis: any difference from normal population?. Asia Pac Allergy 2012; 2 (01) 45-48
• 7 Ozkara Sule, Keles E, Ilhan N, Gungor H, Kaygusuz I, Alpay HC. The relationship between Th1/Th2 balance and 1α,25-dihydroxyvitamin D₃ in patients with nasal polyposis. Eur Arch Otorhinolaryngol 2012; 269 (12) 2519-2524
• 8 Wjst M, Hyppönen E. Vitamin D serum levels and allergic rhinitis. Allergy 2007; 62 (09) 1085-1086
• 9 Mulligan JK, Bleier BS, O'Connell B, Mulligan RM, Wagner C, Schlosser RJ. Vitamin D3 correlates inversely with systemic dendritic cell numbers and bone erosion in chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis. Clin Exp Immunol 2011; 164 (03) 312-320
• 10 Partyka R, Pałac J, Paluch Z. , et al. Evaluation of usefulness of hs-CRP and ferritin assays in patients with nasal polyps. Dis Markers 2014; 2014: 794060
• 11 Yıldırım YS, Apuhan T, Koçoğlu E, Simşek T, Kazaz H. High sensitivity C-reactive protein levels in chronic rhinosinusitis and allergic rhinitis. Kulak Burun Bogaz Ihtis Derg 2011; 21 (05) 266-269
• 12 Büyüköztürk S, Gelincik AA, Genç S. , et al. Acute phase reactants in allergic airway disease. Tohoku J Exp Med 2004; 204 (03) 209-213